In a new filing with the Securities and Exchange Commission, Bain Capital‘s Brookside Capital disclosed increasing its activist stake in PTC Therapeutics......
(read more)October 16 - Hedge Funds, News - Comments
As a new filing with the Securities and Exchange Commission showed today, Samuel Isaly‘s Orbimed Advisors have trimmed its exposure to Relypsa Inc......
(read more)September 19 - Hedge Funds, News - Comments
Scopia Capital Management has disclosed in a recent regulatory filing with the Security and Exchange Commission that it has acquired 4.2 million shares......
(read more)August 12 - Hedge Funds, News - Comments
As a new form 4 filing with the Securities and Exchange Commission showed, Julian and Felix Bakers‘ Baker Bros Advisors, a fund focused on the......
(read more)June 25 - Hedge Funds, News - Comments
Over the past week, a few multi millionaire insider purchases caught my eye. In this article, I will look into three particular companies that saw their......
(read more)June 10 - Hedge Funds, Insider Trading - Comments
Peter Kolchinsky‘s hedge fund, Ra Capital Management disclosed upping its position in Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) some more.......
(read more)November 22 - Hedge Funds, News - Comments
RA Capital, Achillion Pharmaceuticals: In a 13G filing with the SEC, Peter Kolchinsky‘s RA Capital disclosed that it owns nearly 15% of infectious......
(read more)October 4 - Hedge Funds, News - Comments
As fast as we can type this, Phill Gross and Robert Atchinson’s hedge fund, Adage Capital Partners, disclosed ownership of about 3.7 million shares......
(read more)September 9 - News - Comments
Is Halozyme Therapeutics, Inc. (NASDAQ:HALO) a good investment? Now, according to many investors, hedge funds are seen as delayed, outdated financial......
(read more)September 4 - News - Comments
Should Perrigo Company (NYSE:PRGO) investors track the following data? In the eyes of many traders, hedge funds are perceived as useless, outdated financial......
(read more)September 3 - News - Comments
What’s a smart HeartWare International Inc (NASDAQ:HTWR) investor to do? In the 21st century investor’s toolkit, there are plenty of metrics......
(read more)September 3 - News - Comments
To the average investor, there are many gauges shareholders can use to analyze the equity markets. Some of the most innovative are hedge fund and insider......
(read more)September 2 - News - Comments
Is it smart to be bullish on Sequenom, Inc. (NASDAQ:SQNM)? If you were to ask many traders, hedge funds are seen as useless, outdated investment vehicles......
(read more)August 30 - News - Comments
Is Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) a good investment? To the average investor, there are dozens of indicators market participants can use......
(read more)August 30 - News - Comments
Should a DexCom, Inc. (NASDAQ:DXCM) investor track the following data? If you were to ask many traders, hedge funds are assumed to be overrated, old......
(read more)August 30 - News - Comments
Should investors be bullish on Incyte Corporation (NASDAQ:INCY)? In the 21st century investor’s toolkit, there are many gauges shareholders can use......
(read more)August 30 - News - Comments
If you were to ask many traders, hedge funds are viewed as useless, outdated financial tools of a forgotten age. Although there are more than 8,000 hedge......
(read more)August 29 - News - Comments
Is Regeneron Pharmaceuticals Inc (NASDAQ:REGN) a good investment? If you were to ask many investors, hedge funds are viewed as delayed, outdated investment......
(read more)August 29 - News - Comments
To many traders, hedge funds are perceived as delayed, outdated investment vehicles of an era lost to time. Although there are In excess of 8,000 hedge......
(read more)August 28 - News - Comments
In today’s marketplace, there are many metrics market participants can use to track publicly traded companies. A pair of the most innovative are hedge......
(read more)August 28 - News - Comments
In the eyes of many investors, hedge funds are seen as overrated, old financial tools of a forgotten age. Although there are over 8,000 hedge funds in......
(read more)August 28 - News - Comments
Onyx Pharmaceuticals, Inc. (NASDAQ:ONXX) investors: listen up. In the 21st century investor’s toolkit, there are tons of metrics shareholders can use......
(read more)August 26 - News - Comments
In the 21st century investor’s toolkit, there are many indicators market participants can use to watch stocks. A couple of the best are hedge fund and......
(read more)August 26 - News - Comments
Should you be crazy about BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)? In the financial world, there are dozens of gauges shareholders can use to analyze......
(read more)August 26 - News - Comments
Is Mylan Inc. (NASDAQ:MYL) a buy? To many investors, hedge funds are assumed to be overrated, old financial vehicles of an era lost to time. Although......
(read more)August 25 - News - Comments
Is Amarin Corporation plc (ADR) (NASDAQ:AMRN) a buy? In the financial world, there are many metrics shareholders can use to track their holdings. A duo......
(read more)August 23 - News - Comments
Merck & Co., Inc. (NYSE:MRK) has had a consistently swell 2013, and the hits just keep on coming. Now, according to many investors, hedge funds are......
(read more)August 21 - News - Comments
AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO) was in 9 hedge funds’ portfolio at the end of the first quarter of 2013. AVEO investors should pay attention......
(read more)June 21 - News - Comments
Luminex Corporation (NASDAQ:LMNX) investors should be aware of a decrease in hedge fund sentiment lately. In the 21st century investor’s toolkit, there......
(read more)June 14 - News - Comments
